Population-Based Viral Antibody Profiles of Preschool Children in Burkina Faso

Cindi Chen1, Armin Hinterwirth1, Mamadou Ouattara2

  • 1Francis I. Proctor Foundation, University of California-San Francisco, San Francisco, California.

Insights

In Burkina Faso, preschool children

Area of Science:

  • Immunology and Infectious Diseases
  • Global Health
  • Pediatrics

Background:

  • Virus-associated infections are a significant cause of childhood illness and death in sub-Saharan Africa.
  • Understanding antibody responses to various viruses is crucial for public health interventions in this region.
  • The emergence of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) prompted investigations into its impact on existing immune profiles.

Purpose of the Study:

  • To simultaneously assess antibody responses to multiple viruses in children in Burkina Faso.
  • To investigate the influence of age, sex, SARS-CoV-2 pandemic onset, and azithromycin mass drug administration (MDA) on viral sero-reactivity.
  • To determine if SARS-CoV-2 emergence altered immune responses to other common childhood viruses like RSV and poliovirus.

Main Methods:

  • Exploratory, population-based study utilizing programmable phage immunoprecipitation and sequencing.
  • Analysis of dried blood spots from 251 children (12-59 months) previously enrolled in the Community Health with Azithromycin Treatment trial.
  • Linear mixed effects models were employed to examine associations between viral antibody response and demographic/intervention factors.

Main Results:

  • SARS-CoV-2 sero-reactivity showed a negative correlation with age, but no significant association with sex or azithromycin MDA.
  • Immunoreactivity to respiratory syncytial virus (RSV) was not significantly altered by the emergence of SARS-CoV-2.
  • No detectable differences in poliovirus 1 sero-reactivity were observed in relation to azithromycin MDA.

Conclusions:

  • While SARS-CoV-2 sero-reactivity is age-dependent, its emergence did not appear to impact antibody responses to RSV or poliovirus vaccination in young children in Burkina Faso.
  • Further longitudinal studies in diverse at-risk populations are recommended to enhance understanding and develop preventive strategies against childhood morbidity.
  • The findings contribute to the understanding of viral immune dynamics in African children during the COVID-19 pandemic.

Related Concept Videos

Single Nucleotide Polymorphisms-SNPs01:05

Single Nucleotide Polymorphisms-SNPs

A single nucleotide polymorphism or SNP is a single nucleotide variation at a specific genomic position in a large population. It is the most prevalent type of sequence variation found in the human genome. Point mutations that occur in more than 1% of the population qualify as SNPs. These are present once every 1000 nucleotides on an average in the human genome. Replacement of a purine with another purine (A/G) or a pyrimidine with another pyrimidine (C/T) is known as a transition. In contrast,...
Development of Immunocompetence01:22

Development of Immunocompetence

The initiation of cell-mediated immunity can be observed as early as the third month of fetal growth, with active antibody-mediated immunity following approximately one month later.
The initial cells that migrate from the fetal thymus settle within the skin and epithelial tissues lining the mouth, digestive tract, and in females, the uterus and vagina. These cells, including skin-based dendritic cells, serve as antigen-presenting cells, playing a key role in T cell activation.
Subsequent T...
Poliomyelitis01:17

Poliomyelitis

Poliomyelitis is caused by poliovirus, a small, non-enveloped, positive-sense RNA virus of the Picornaviridae family and Enterovirus genus. Transmission occurs primarily via the fecal-oral route, often through ingestion of contaminated water or food. The virus initially replicates in the oropharynx and intestinal mucosa, particularly in lymphoid tissues such as the tonsils, Peyer’s patches, and regional lymph nodes. Primary viremia follows, allowing dissemination throughout the body.In most...
Respiratory Syncytial Virus Disease01:29

Respiratory Syncytial Virus Disease

Human respiratory syncytial virus (RSV) is a widespread pathogen that primarily targets infants and young children but also poses a serious health risk to elderly and immunocompromised individuals. Belonging to the Pneumoviridae family, RSV is a negative-sense, single-stranded RNA virus within the Pneumovirus genus. Its global health burden is significant, with millions of cases annually resulting in hospitalizations and mortality, particularly in resource-limited settings. Although most...
Malaria01:29

Malaria

Malaria pathogenesis in humans reflects a delicate interplay between parasite biology and host response. Clinical illness reflects a host’s immune response to the parasite’s asexual replication cycle, which is often asymptomatic in individuals with partial immunity. From the parasite's perspective, transmission between mosquito and human with minimal host pathology is evolutionarily advantageous. Among the six Plasmodium species infecting humans, P. falciparum and P. vivax dominate in global...
Toxoplasmosis01:28

Toxoplasmosis

Toxoplasmosis, a zoonotic disease caused by the protozoan Toxoplasma gondii, poses significant public health challenges globally due to its high seroprevalence and varied clinical manifestations. As an obligate intracellular parasite, T. gondii can infect all warm-blooded vertebrates, but felids are its only definitive hosts, shedding unsporulated oocysts into the environment. Humans typically acquire the infection through ingestion of tissue cysts in undercooked meat or oocysts from...